Breaking News
Get 40% Off 0
☕ Buy the dip? After losing 17%, Starbucks sees an estimated 20% upside. See the top Undervalued stocks! Unlock list
Close

AstraZeneca PLC ADR (AZNPy)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AstraZeneca ADR historical data, for real-time data please try another search
46.20 0.00    0.00%
05/10 - Delayed Data. Currency in EUR ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 46.20 - 46.20
Type:  Equity
Market:  Germany
ISIN:  US0463531089 
AstraZeneca ADR 46.20 0.00 0.00%

NASDAQ:AZNPy Financials

 
This summary provides an overview of the most significant critical numbers from each of the Astrazeneca financial reports, including theAstraZeneca PLC ADR income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the NASDAQ:AZN financials over time via breakdowns of their annual reports.
AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

AZNPy Income Statement & Profits

Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012
Total Revenue 5.59 6.24 7282 6682
Gross Profit 4.84 5.43 5945 5422
Operating Income 4.71 5.33 1964 2156
Net Income -0.3 14.23 1521 1525

AZNPy Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012
Total Assets 154.6 161.62 53534 52448
Total Liabilities 0.48 2.36 29803 30410
Total Equity 154.12 159.25 23731 22038

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  0.00%
 Cash  Net Change in Cash
Period Ending: Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012
Period Length: 6 Months 3 Months 12 Months 9 Months
Cash From Operating Activities -0.3 14.23 6948 4100
Cash From Investing Activities -1238 -364 -1859 -1345
Cash From Financing Activities -4.83 -5.26 -4923 -4398
Net Change in Cash -5.13 8.97 162 -1633
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AZN Price Commentary

Write your thoughts about AstraZeneca PLC DRC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai May 09, 2021 11:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thanks you AstraZ. Bullish. management services.
Woon soo Lee
Woon soo Lee May 01, 2021 18:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
54 to 64 bullish sentiments again volatility trading
Poh Meng Kong
Poh Meng Kong Feb 25, 2021 22:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$68 in 1 month
Nelson T Machin
Nelson T Machin Feb 01, 2021 15:49
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Do you this will grow as EU has approved their Covid vaccine?
Frans Caruana
Frans Caruana Jan 25, 2021 20:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will reach 100 in 6 months time
Arek Rusak
Arek Rusak Dec 24, 2020 13:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think the vaccine is nothing next to the antibody coctail, known as AZD7442 that Astra is working on at the momenthttps://www.reuters.com/article/health-coronavirus-astrazeneca-antibody-idUSKBN28100E
bojidar zarev
bojidar zarev Dec 14, 2020 18:56
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good buy in the long term.
Andre Low
Andre Low Dec 12, 2020 13:18
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.wsj.com/articles/astrazeneca-agrees-to-buy-alexion-for-39-billion-11607778687?redirect=amp#click=https://t.co/EeYlRyEn3g
Nabeel Qabane
Nabeel Qabane Nov 30, 2020 10:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I expect it to reach $ 100 next month
Sandeep Agarwal
Sandeep Agarwal Oct 12, 2020 17:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
for super rich returns
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email